ArticleBMC musculoskeletal disorders2026
Does metabolically healthy obesity increase the risk of knee and hand osteoarthritis? A population-based cohort study.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Knee Osteoarthritis and Metabolic Disorders: Practical Aspects from Primary Healthcare.Journal of clinical medicine · 2026Article
- Chair stand performance and symptomatic knee osteoarthritis onset: a prospective cohort study.Rheumatology international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundTo evaluate the independent and combined effects of metabolic abnormalities and obesity on the risk of knee and hand osteoarthritis (KOA and HOA).
methodsParticipants from the UK Biobank were classified into four phenotypes: metabolically healthy non-obesity (MHN), metabolically healthy obesity (MHO), metabolically unhealthy non-obesity (MUN), and metabolically unhealthy obesity (MUO). Accelerated failure time (AFT) models were applied to assess the associations of these phenotypes with the risk of KOA and HOA.
results389,807 participants (mean 56.4 years, 54.0% female) without KOA or HOA at baseline were included. Compared to MHN, both MHO and MUO significantly accelerated the incidence of KOA (MHO: Time Ratio [TR] = 0.37, 95% confidence interval [CI]: 0.33–0.40; MUO: TR = 0.37, 95%CI: 0.35–0.39), and MUO accelerated the risk of HOA (TR = 0.81, 95%CI: 0.70–0.93) over 13.0 years. The incidence of KOA was also higher in MUN participants (TR = 0.87, 95%CI: 0.83–0.91), although the effect of metabolic abnormalities on KOA risk disappeared after controlling for body mass index (BMI) (TR = 1.03, 95%CI: 0.99–1.07). There was a significant interaction between metabolic status and BMI for KOA risk, where the association between BMI and the risk of KOA was stronger in metabolically healthy participants (TR = 0.88 per 1 kg/m2 increase in BMI, 95%CI: 0.87–0.89).
conclusionsHigh BMI elevates the risk of both KOA and HOA irrespective of metabolic status, and the increased risk of KOA attributed to high BMI is more evident in metabolically healthy participants. Weight management remains a key to OA prevention, especially for weight-bearing joints. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.